Thomas Zalewski, chair of the firm's Healthcare and Life Sciences practice, handles a wide range of strategic transactions, including mergers and acquisitions, divestitures, joint ventures and strategic alliances, primarily in the life sciences, technology and energy industries.
Thomas also serves as outside general counsel to emerging and middle-market companies, where he handles a broad array of strategic and commercial matters, including licensing and other intellectual property-based transactions, equity and debt financings, restructurings, and commercial disputes, as well as executive employment and corporate governance matters.
Previously, Thomas served as a senior member of the legal team at Dendrite International, Inc. (now IMS Health), a publicly held provider of technology, sales and marketing solutions to the global life sciences industry, where he advised executive management in connection with some of the company’s highest profile initiatives.
Thomas helps clients grow and protect enterprise value by fostering close, long term client relationships that are based upon a deep understanding of their business, objectives and tolerance for risk.
Representative Life Sciences Matters:
Represented a specialty pharmaceutical company in connection with recovering certain product registrations and intellectual property rights out of a bankrupt commercialization partner
Represented a global nutritional supplement company in connection with purchasing assets of a competitor out of bankruptcy
Represented a specialty cosmetics company in connection with corporate restructuring matters
Represented a publicly held medical device manufacturer in connection with strategic and commercial matters
Represented a global food and beverage company in connection with a joint venture to develop and commercialize nutraceutical-based products
Represented an injectables contract manufacturer in connection with strategic alliances and commercial matters
Represented French medical device manufacturer in connection with its U.S. commercial matters
Represented the animal health division of a global pharmaceutical company in connection with strategic licensing and product distribution matters
Represented an investor in connection with a minority investment in a Cyprus-based medical device company
Represented an emerging medical device company in connection with its capital raising activities
Representative Energy Industry Matters:
Represented a large energy company as purchaser in an auction process for a 550MW electrical generation facility in Rhode Island
Represented a large energy company as purchaser in an auction process for the purchase of a 244MW electrical generation facility in Connecticut
Represented a large energy company in the sale of its multi-state demand response business
Represented a merchant generation company in the sale of a 256 MW cogeneration facility in Massachusetts
Represented a large energy company in its purchase of compressed natural gas stations across multiple states
Other Representative Engagements:
Represent a diversified German manufacturing concern in connection with the establishment of new business lines in the U.S.
Represent a science and technology center in connection with its exhibition procurement and loan activities
Represented the U.S. partner of an emerging global technology consulting company in the sale of business
Represented a global pharmaceutical services company in connection with global privacy and corporate matters